CIRM awards $1.3M to Greenstone Bio for stem cell research involving iPSC-derived cardiovascular cells accelerated by artificial intelligence and machine learning.
Palo Alto, CA, Oct 04, 2022 – Greenstone Biosciences, Inc. (“Greenstone Bio”), a commercial-stage computational biology company, announces that the Company has received a DISC0 grant funding from the California Institute of Regenerative Medicine (CIRM). [Read more…]